It is not easy to get FDA approval and frankly I am disappointed that the market has not reacted positively to the news. MSB despite the progress it has made did not get FDA approval for its Ryoncil treatment for aGVHD. The FDA requested for another trial. ARIX has fully disposed its shares in PSX and hopefully the price will move upwards. We know that the local plant producing Bronchitol will now be fully swing in production to supply the US market which is huge and with the income derived the price is bound move upwards. Good times are ahead.
PXS Price at posting:
9.6¢ Sentiment: Hold Disclosure: Held
